During the previous FP7-SME–2008–1-FallWatch Research programme, a miniaturized fall detection device, Vigi´Fall™ has been developed, achieving the following characteristics and performances:- Ergonomics: Vigi’Fall has been miniaturized to a scale 50% smaller than current devices. Additionnal biocompatible materials for the casing and the adhesive patche make it comfortable and easy to stick to the user’s skin- Reliability: to tackle the high rate of false alarms that hinder the market, the FALLWATCH Consortium has develop a enhanced data fusion algorithm that crosses check accelerometers and heartbeat frequency meter monitored by the wearable device and infra red environmental information from the user’s homeThe present project will represent the next step, i.e. the progression from research developments and lab-prototype to industrialization and commercializable products. It will aim at:- Adapting the technology to the US standards, controlling the performances of the device, optimizing the component selection, process and overall cost- Organizing clinical trials to demonstrate and validate the high performances of Vigi”Fall- Obtaining CE marking and FDA clearance to launch Vigi’Fall to the EU and US markets- Develop the best business strategy and commercialization routesFALLWATCH Demo will offer to the market a new generation of practical, easy to use and install, reliable fall detector, which thanks to a strong supply chain of SMEs (Vigilio, BSE, PMBL & Plastod) and a large company (AEMtec) will enable an enhanced quality of life to millions of European citizens, saving more than 10.000 hospitalizations and above 3.000 premature deaths caused by falls.